Unifying Oncologists & Pathologists
A Peer-Reviewed Journal September 2014 • Volume 3 • Number 6
PM O
BIOMARKERS • TARGETED THERAPIES • DIAGNOSTICS
Personalized Medicine in Oncology TM
INTERVIEW WITH THE INNOVATORS Tissue Phenomics: Closing the Gap Between Genomic Information and Patient Outcomes. An Interview With Thomas P. Heydler, CEO of Definiens............................................Page 314
IMMUNOTHERAPY FDA Approves Pembrolizumab for Advanced Melanoma....................................Page 320
HEMATOLOGIC MALIGNANCIES Highlights From the 6th International Symposium Acute Promyelocytic Leukemia......................Page 324
LUNG CANCER Navigating the Molecular Testing Landscape in Lung Cancer.................................................. Page 334
VALUE-BASED CANCER CARE Determining the Value of Cancer Therapies: A Paradigm Shift Focused on Quality, Outcomes, and Cost........................................................Page 348
THE LAST WORD The Personalized Medicine Coalition and Turning the Tide Against Cancer Through Sustained Medical Innovation.......................Page 350 GLOBAL BIOMARKERS
CONSORTIUM Clinical Approaches to Targeted Technologies ™
The official publication of
GLOBAL BIOMARKERS CONSORTIUM Clinical Approaches to Targeted Technologies ™
WORLD CUTANEOUS MALIGNANCIES CONGRESS
© 2014 Green Hill Healthcare Communications, LLC An affiliation of The Lynx Group
WORLD CUTANEOUS
In partnership with
™